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Abstract
Background: This study is a cross sectional analysis, aiming to evaluate if atopy is as a risk factor
for exercise induced bronchoconstriction (EIB) among Tunisian athletes.
Methods: Atopy was defined by a skin prick test result and EIB was defined as a decrease of at
least 15% in forced expiratory volume in one second (FEV1) after 8-min running at 80–85%
HRmaxTheo. The study population was composed of 326 athletes (age: 20.8 ± 2.7 yrs – mean ±
SD; 138 women and 188 men) of whom 107 were elite athletes.
Results: Atopy was found in 26.9% (88/326) of the athletes. Post exercise spirometry revealed the
presence of EIB in 9.8% of the athletes including 13% of the elite athletes. Frequency of atopy in
athletes with EIB was significantly higher than in athletes without EIB [62.5% vs 23.1%, respectively].
Conclusion: This study showed that atopic Tunisian athletes presented a higher risk of developing
exercise induced bronchoconstriction than non-atopic athletes.
Background
Many athletes have breathing difficulties during or after
athletic events and practice. Recently, several reports have
delineated a significantly high prevalence of asthma
symptoms in athletes [1-3]. Many triggers have been
reported to induce the development of exercise-induced
bronchoconstriction (EIB) also called exercise-induced
asthma (EIA), notably the exposure to cold and dry air;
humidity [4], thermal phenomena [5], and atopic status
which also appears to be determinant. The reasons for this
observation are still debated, but different mechanisms
linked to the intensity of physical activity and atopy in
athletes are probably involved [6,7]. Helenius et al. [7]
indicated that atopic disposition increased the risk for
asthma. Atopy is a form of immunological reactivity in
which a reaginic antibody is readily produced in response
to everyday exposure of a subject to common allergens in
the environment [8]. Atopic reactivity can be verified by
serological tests or by skin-prick tests to detect antigen-
specific IgE antibodies [9].
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Only a few studies have used objective methods to detect
atopic allergy in athletes. In the study by Zwick et al.[10]
9 out of 14 swimmers had at least one positive reaction to
the skin-prick test. Of 42 cross-country skiers studied by
Larsson et al., [11], 29% were atopic according to the of
results skin-prick test. Helenius et al. [7] found that 48%
of the athletes and 36% of the control studied subjects
were atopic according to the results of skin-prick tests. In
North Africa, there are marked variations in the preva-
lence of asthma symptoms in the general population with
up to 3-fold differences between the two periods pre- and
post-1990; asthma prevalence showing a particularly
marked increase during the last 10 years [12]. Recently, in
the only report concerning the incidence of asthma in
Tunisian athletes, Sallaoui et al. found that 13% of elite
athletes (14/107) had EIA [13]. Tunisia as a North African
country is characterized by a westernised lifestyle and epi-
demiological transition in which communicable diseases
are receding and non-communicable diseases are emerg-
ing. We speculate that the westernized lifestyle and pollu-
tion are factors associated with the increased risk of atopy
in Tunisians [12]. However, the prevalence of EIB associ-
ated with the increased risk of atopy among the Tunisian
athletes is not known. Moreover, many athletes are reluc-
tant to report asthma symptoms to a coach fearing that
they will no longer be allowed to play or that they may be
eliminated from the team or not be selected for events
owing to their EIB. In that context, when discussing
asthma with athletes, it is important for them to be reas-
sured that with accurate diagnosis and proper manage-
ment, they can still participate, even at the highest levels
of competition.
The aim of this study was to establish risk of associations,
specifically if atopy is as a risk factor for EIB among Tuni-
sian athletes.
Methods
Study design
This study was conducted from November to mid-Decem-
ber 2003. During the testing days, the mean temperature
and relative humidity were 10 ± 4°C (Range 6 – 14°C)
and 45.6 ± 12% (Range 38 – 55%), respectively. Prior to
exercising, a familiarisation session was conducted to col-
lect demographic information and to familiarize the sub-
jects to the study protocol and its field investigators. This
session included a skin-prick test, a review of the study
protocol, and a spirometry pre-test.
Subjects
Three hundred and twenty-six athletes (188 males and
138 females, mean age 20.8 ± 2.7 years; range 17–24
years) of whom 107 were elite athletes training regularly
(mean weekly training duration 18.3 ± 1.9 h, range 16 –
21 h), and 219 regional athletes regularly involved in
regional championships (mean weekly training duration
10 ± 1.7 h, range 8 – 12 h) participated in the study. The
athletes were divided into three groups according to their
type of sport: (1) speed and power sport athletes (n =
114), endurance athletes (n = 54), and team sport athletes
(n = 158). The main events of the speed and power ath-
letes were weightlifting (n = 13), sprinting (100 to 400
meters, hurdles; n = 31), jumping (n = 15), taekwondo (n
= 27), judo (n = 18), and gymnastics (n = 10). The endur-
ance athletes were the long-distance runners competing in
events from 800 meters to the marathon (n = 54). The
team sport athletes were handball (n = 28), basketball (n
= 25), soccer (n = 44), rugby (n = 33), and volleyball (n =
28) players. All subjects were clinically healthy and had
no history of recent infection disease, asthma or cardiores-
piratory disorders. Each participant underwent a skin-
prick test and resting spirometry testing before and after
exercise. The research protocol which was in accordance
with the declaration of Helsinki, was approved by the
Research Ethics Committee of the Faculty of Medicine,
University of Sousse, Tunisia. All participants volunteered
to participate to the study and were fully informed about
the nature of the testing as well as the associated risks, and
signed written consent forms before the experiments.
Outcome measures
1. Skin-Prick Test
Skin-prick test were performed with seven common air-
borne allergens and positive (histamine dihydrochloride,
10 mg/ml) and negative (solvent) control solutions from
ALK (Soluprick SQ, 10 histamine equivalent pricks (HEP);
Allergologisk Laboratorium, Horsholm, Denmark). The
allergens were as follows: birch, timothy, meadow fescue,
and mugwort pollen and cow dander; the mite Dermat-
ophagoides pteronyssinus; and spores of the mould Cladospo-
rium herbarum. We considered an allergen-specific skin
test response positive if the skin test panel was valid and
the difference in the mean of the wheal's lengths and
widths between the allergen-specific test and the negative
control was at least 3 mm. A skin test panel was consid-
ered valid if the difference between the mean wheal diam-
eters of the positive and negative controls was at least 1
mm.
2. Measurement of forced expiratory volume in one second (FEV1)
FEV1 is the volume of air that can be forced out in one sec-
ond after taking a deep breath; this value is considered as
an important measure of pulmonary function that can
indicate airway obstruction. The FEV1 test was carried out
using a portable spirometer (Auto Spiro Pal; Minato Med-
ical Science. Co., Ltd, Japan). The athletes performed the
baseline test three times and the best result was recorded.
The subject was seated comfortably, and she/he was
instructed to take-in a full breath then to close the lips
around the mouth piece and blow-out as hard and rapidlyBMC Pulmonary Medicine 2009, 9:8 http://www.biomedcentral.com/1471-2466/9/8
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as possible. Inspiration had to be full and unhurried, and
tested expiration had to be continuous without pause. The
technique was demonstrated to each subject and the result
was expressed in litres per second. FEV1 was measured at
rest (pre-exercise) and at 0, 5, 10, 15, 20 and 30 min after
completion of exercise. The subjects were diagnosed with
asthma if any of the post-exercise FEV1 values was at least
15% lower than the pre-exercise FEV1 measurement. This
level of 15% was chosen in accordance with the recom-
mendations of the American Thoracic Society which sug-
gested that this level is optimal for outdoor conditions
[14,15].
3. Exercise
The athlete ran for 8 minutes at 80–85% of the estimated
maximum heart rate (HRmaxTheo) [16]. The exercise was
performed without warm-up and the subjects ran in
groups of four subjects along an outdoor track. During the
run, the subjects were equipped with portable heart rate
monitors (Polar S610, Oy, Kempele, Finland) set to
record HR at 5 s intervals. Before exercise, each subject was
informed about the range of HR at which she/he had to
run according to her/his HRmaxTheo calculated accord-
ing to Crapo et al.[15]: HRmaxTheo = (220-age) bpm. Tar-
get HR zones were pre-set on the programmable HR
monitors so that the athletes were guided by audio alarms
to keep their HRs between 80–85% of the estimated
HRmax. Subjects attained the target zone in 45–60 s from
the beginning of the run and the remainders of the 8 min
run
Statistical analyses
Student's t-test for independent samples was used to
determine the differences between the averages of the var-
iables in the two groups' variables (demographic variables
and FEV1). A Chi-square test was used to assess the asso-
ciation between atopic and non-atopic athletes (percent-
age). Significance was set at an alpha level of 0.05, and all
statistical analyses were conducted using the statistical
package for the Social Sciences (SPSS, Version 13.0, SPSS
Inc, Chicago, IL) and medical statistical methods (Tool of
medical-statistical calculations allowing the evaluation of
the value Diagnostic) [17].
Results
All the 326 studied athletes completed the skin-prick test,
the Spirometric test, and the running test. Anthropometric
and lung function data recorded at rest are presented in
Table 1. Exercise-induced bronchoconstriction was
observed in 9.8% (32 out of 326) of the athletes and in
13% (14 out of 107) of the elite athletes. When individual
data for each subject were pooled and analyzed by para-
metric statistical analysis (Student's t-test), no significant
intergroup differences were observed in demographic var-
iables or in pre-exercise FEV1 values (Table 1).
Figure 1 shows the Spirometric results (mean) for the
EIB(+) group (athletes who developed exercise-induced
bronchoconstriciton, n = 32) and EIB(-) group (athletes
with no observed EIB, n = 294). Intergroup comparison
indicated that athletes with EIB had significantly lower
post-exercise FEV1 than the athletes without EIB (p <
0.001) with respective values of 16.85 ± 2.30% and 4.09
± 3.51% of drop in FEV1.
Atopy according to skin-prick test results was found in
26.9% (88 out of 326) of all athletes, of these, 20 subjects
presented EIB. Chi-square indicated that the frequency of
atopy in athletes with EIB was significantly higher than in
athletes without EIB [62.5% (20/32) vs 23.1% (68/294),
respectively].
Table 1: Characteristics of the study population, Mean ± SD anthropometric and spirometric variables of the studied group
Variables S EIB (+) EIB (-)
Number 326 32 294
Age (years) 20.8 ± 2 69 21.13 ± 2.64 20.56 ± 2.69
Weight (kg) 66.76 ± 9.72 66.51 ± 7.96 67.35 ± 8.26
Height (m) 1.75 ± 0.64 1.69 ± 0,14 1.76 ± 0.69
BMI (Kg/m2) 20 99 ± 3.66 20.89 ± 4.20 21.01 ± 3.59
FEV1 at rest (l/mn) 4.25 ± 0.86 4.03 ± 0.75 4.28 ± 0.88
Relative value of FEV1 (%) 121 ± 13 122 ± 18 119 ± 19
S, the study population; EIB (+) showed EIB (Exercise Induced Bronchoconstriction); EI (-) did not showed EIB; FEV1, forced expiratory volume in 
one second; Relative value of FEV1 = percentage of theoretical values [32]BMC Pulmonary Medicine 2009, 9:8 http://www.biomedcentral.com/1471-2466/9/8
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Discussion
This study showed that atopy is a major risk factor for
diagnosis of EIB in Tunisian athletes. Post-exercise
spirometry revealed the presence of EIB in 9.8% (32/326)
of the subjects, this prevalence of EIB is greater than in the
general population [12]. Various studies in North Africa
have been conducted to determine the prevalence of
asthma but they have differed markedly, probably
because of methodological considerations. The preva-
lence ranged from 2.4 to 3.4% in studies before 1990 and
from 6 to 12% in the later ones [12]. In a study using
"International Study of Asthma and Allergies in Child-
hood" (ISAAC) methodology conducted in the Tunis
region on children aged 13–14 years, the prevalence was
found to be 5.4% [12]. Only one recent study has been
performed in Tunisian elite athletes showing EIB in 13%
of the studied subjects [13]. The prevalence of asthma has
ranged from 4% to 59% in various athletes' studies. This
wide variation is mainly due to different types of training
and training environments. Also differences in the defini-
tion and diagnosis of asthma may have had some impact
on the mentioned range. An especially high prevalence of
asthma has been found among those athletes competing
in endurance events such as cycling, swimming, cross-
country skiing, and long-distance running [2-4,6,7].
In order to estimate the prevalence of EIB in Tunisian ath-
letes we chose to use a method for evaluating the respira-
tory condition of athletes, the most common is the
change in FEV1 before and after exercise. This method is
among the most widely used, and allows the study of a
large number of individuals and avoids the task of recruit-
ing subjects for laboratory testing. It also requires only a
few minutes for testing and is relatively inexpensive. One
of the limits of the present study is the difficulty to obtain
standardized climatic conditions (temperature and
humidity) but this is a common limitation of most out-
door studies.
It was found that 13% (14/107) of elite athletes suffered
from EIB. Many studies have shown that the risk of devel-
oping EIB is increased in the elite athletic population [2-
4,18,19]. The initial report about the incidence of EIA or
EIB in elite athletes included the somewhat surprising
finding that 11% of the US 1984 Summer Olympic Team
experienced EIB [18]. In the 2000 summer Olympic
Games in Sydney, 607 athletes (5.5% of the total) used
inhaled B2-adrenoceptor agonists (β2-agonists) to treat
active asthma [19]. This was a significant increase over the
preceding 1996 summer Olympic Games in Atlanta,
when only 383 athletes (3.6% of total) provided notifica-
Percentage change from baseline in forced expiratory volume in one second (FVE1) after exercise Figure 1
Percentage change from baseline in forced expiratory volume in one second (FVE1) after exercise. Spirometric 
results (mean) for the EIB(+) group (athletes who developed exercise-induced bronchoconstriciton, n = 32) and EIB(-) group 
(athletes with no observed EIB, n = 294). Intergroup comparisons of all data points indicated that EIB(+) had significantly lower 
FEV1 than EIB(-). *: p < 0.05; **: p < 0.001.
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tion of use of B2-agonists [19]. Recently Alaranta et al. [2]
reported that physician-diagnosed asthma and use of
asthma medication were more common among Olympic
level athletes than in the Finnish general population of
the same age. Endurance athletes such as cross-country
skiers, long-distance runners and swimmers suffered
asthma more often than athletes in other events.
Among the objective methods for evaluating the respira-
tory condition of athletes, the most common is the
change in FEV1 before and after exercise. Metacholine or
histamine challenge tests are also used to determine the
degree of EIB or airway hyper-responsiveness (AHR) in
athletes. These standardized methods to evaluate the type
and magnitude of airway response, i.e. 15 or 20% fall in
FEV1 at specific provocation doses (PD15 or PD20) or
provocation concentration (PC20) of methacholine or
histamine were used to make the diagnosis of EIB. The
prevalence of EIB obtained by these methods is much
higher than that obtained in the present study, generally
above the level of 20% (ranging from 19 to 76%) [20].
Helenius et al. [7] indicated that atopy is a major risk fac-
tor for EIB. In the present study, the diagnosis of atopy
was based on the positive response to the skin tests under-
went by all the subjects. A more objective evaluation by
blood testing for the specific circulating IgE would proba-
bly allow the detection of more atopic subjects, but the
skin-prick test is much more easier to administer ''on the
field" in large populations. In total, 326 athletes under-
went skin tests; atopy was identified in 26.9% (88/326).
This prevalence of atopy among Tunisian athletes was not
much different from the general population [21]. In the
literature, some authors indicated that atopy in athletes
may be partly related to exercising in extreme or particular
environmental conditions which may favour its expres-
sion in the predisposed subjects [23,24].
An underestimation of the prevalence of atopy and EIB in
our population might, however, come from the non-
inclusion of swimmers. Indeed, it was recently shown that
the swimmers are at higher risk for atopy and EIB devel-
opment than other athletes [7]. In this context, in Europe
and the USA, up to 1970, episodes of atmospheric pollu-
tion were frequently responsible for acute mortality epi-
demics by cardiovascular and respiratory diseases. The
responsibility for such events was attributed to high con-
centrations of sulphur dioxide and particulate matter in
the air of cities, usually due to unfavorable meteorological
conditions and air stagnation. Urban air pollution is still
highly prevalent in some developing countries [24].
Moreover, urban type pollution is still of major concern in
Western countries with an increase in automobile-
induced pollution. Throughout the world, indoor air pol-
lution, tobacco smoking, and occupational exposures are
of great concern [25].
Environmental factors involving the type and content of
the inhaled air could play an important role. Even if most
sports are practised in various air conditions all year long,
many sports are predominantly practised either in cold,
dry or humid air [26]. For athletes who train outdoors, the
quality of the inhaled air varies and the presence of differ-
ent pollutants may contribute to the development of EIB
[26]. For the athletes who practise their sport in indoor
areas, the exposure to such contaminants and to a variety
of volatile organic compounds could contribute to certain
respiratory problems [27]. Zwick et al. [10] indicated that
swimming at high levels of performance constitutes the
best example of chronic exposure to products and chlo-
ride derivatives of the chlorine used to disinfect swim-
ming pools which may stimulate allergic mechanisms and
facilitate the sensitisation to different allergens.
The present study has shown that that 62.5% of the atopic
Tunisian athletes had EIB (20/32). Hence this prevalence
is significantly greater than that in the athletes without EIB
(62.5% vs. 23.1%) (p < 0.001). In a recent study, Helenius
et al [7] demonstrated a close correlation between the
onset of an EIB and the number of positive responses in
the skin allergic test in athletes: for one to two positive
allergic responses, the risk of an EIB is multiplied by 3.25
whereas for five positive reactions or more, this risk is
multiplied by 4.69. Moreover, the severity of the EIB may
moreover be correlated to the atopy score determined by
adding the average diameters of the papules for all of the
allergens evaluated [11,27]. In this regard Kaelin and
Brandli [29] administered a questionnaire on allergy and
exercise-related respiratory symptoms to 1530 Swiss ath-
letes at national and international levels. Their study
showed a significant correlation between atopy and respi-
ratory symptoms. Helenius et al. [28] in another study
including 58 runners belonging to the national Finnish
team demonstrated that the occurrence of an EIB is
strongly correlated with the seasonal variability. Whereas
for certain athletes, the EIB happens only in winter, for
others it occurs only in pollen-rich periods. These differ-
ences in bronchial responses may be explained by a shift
of the pulmonary inflammatory state in the pollen-rich
period. In this context, it was noted an increase of the
number of eosinophils and the amount of eosinophil cat-
ionic protein in bronchiolo-alveolar lavage fluid in pollen
allergic asthmatics during high pollen periods [30].
The best preventive measure of asthma occurrence is to
achieve optimal control of the disease through athlete
education, and environmental control. The education of
athletes, their families and their coaches is an important
component of the non-pharmacological management of
EIB. To demystify this disease, athletes need to be
informed that their condition is common among those in
high-level competitions and will not limit their perform-
ance if it is treated adequately. Environmental control isBMC Pulmonary Medicine 2009, 9:8 http://www.biomedcentral.com/1471-2466/9/8
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important too, whenever possible. This applies to the
home environment of the athletes, where avoidance of
exposure to relevant allergens and to irritants should be
suggested. It also applies to the training environment; for
example, better ventilation systems in arenas and indoor
pools could possibly help reduce the adverse effects of the
numerous contaminants in suspension in ambient air.
Among the non-pharmacological approaches to EIB, a
warm-up period prior to training or sports events can be
effective in decreasing the degree of bronchoconstriction
through induction of a refractory period, during which
airways become less responsive to exercise [26]. A 10–15
minute warm-up at 60%VO2max can significantly reduce
post-exercise asthma in athletes [31].
Conclusion
This study suggests that an atopic field constitutes cer-
tainly a major risk factor for the development of an EIB in
Tunisian athletes. The increasing prevalence of respiratory
asthma-like symptoms in athlete is opening new paths for
research into airway physiology in extreme conditions.
We suggest that the athletes' medical staff should perform
rigorous control (through a detailed checking of atopy
symptoms and objective measurements such as resting
spirometry) in order to allow early detection of eventual
respiratory problems and provide adequate treatment in
order to avoid EIB.
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